rs267607065
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS2_Supporting
The NM_001174089.2(SLC4A11):c.1147G>A(p.Glu383Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,458,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001174089.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248954Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134770
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1458316Hom.: 0 Cov.: 73 AF XY: 0.00000414 AC XY: 3AN XY: 725374
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Corneal dystrophy, Fuchs endothelial, 4 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: SLC4A11 c.1195G>A (p.Glu399Lys) results in a conservative amino acid change located in the Bicarbonate transporter-like, transmembrane domain (IPR011531) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248954 control chromosomes (gnomAD). c.1195G>A has been reported in the literature in an individual affected with Fuchs endothelial corneal dystrophy. These data suggest the variant may be association with disease. At least two publications report experimental evidence evaluating an impact on protein function, showing reduced expression of mature SLC4A11 protein and disruption of cell surface localization. The following publications have been ascertained in the context of this evaluation (PMID: 18024964, 29327391). No submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
not provided Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 399 of the SLC4A11 protein (p.Glu399Lys). This variant is present in population databases (rs267607065, gnomAD 0.0009%). This missense change has been observed in individual(s) with Fuchs endothelial dystrophy (PMID: 18024964, 25007886). ClinVar contains an entry for this variant (Variation ID: 1323). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC4A11 protein function. Experimental studies have shown that this missense change affects SLC4A11 function (PMID: 18024964, 22072594, 29327391). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at